Carlumab (alternate identifier CNTO 888) is a discontinued human recombinant monoclonal antibody (type IgG1 kappa) that targets human CC chemokine ligand...
7 KB (610 words) - 01:08, 26 June 2023
Agonists: CCL25 CCR10 Agonists: CCL27 CCL28 CCR11 Agonists: CCL19 CCL21 CCL25 Ungrouped Antibodies: Bertilimumab (against CCL11) Carlumab (against CCL2)...
97 KB (11,021 words) - 17:45, 18 September 2024
Avelumab Avdoralimab Belimumab Bleselumab Brodalumab Camidanlumab tesirine Carlumab Cemiplimab Dupilumab Eldelumab Emapalumab Fresolimumab Golimumab Ianalumab†...
38 KB (4,316 words) - 10:24, 26 August 2024
Carefree (feminine hygiene) Cetirizine Doripenem Eluxadoline Carisbamate Carlumab Cladribine Combantrin Doxil Doxorubicin Euthymol Fulranumab Helioplex Hydromorphone...
7 KB (764 words) - 16:32, 18 September 2024
Agonists: CCL25 CCR10 Agonists: CCL27 CCL28 CCR11 Agonists: CCL19 CCL21 CCL25 Ungrouped Antibodies: Bertilimumab (against CCL11) Carlumab (against CCL2)...
67 KB (7,852 words) - 18:22, 10 September 2024
mab mouse Glutamate carboxypeptidase II Y prostate cancer (detection) Carlumab mab human MCP-1 oncology/immune indications Carotuximab mab chimeric endoglin...
136 KB (4,020 words) - 06:13, 27 September 2024
Agonists: CCL25 CCR10 Agonists: CCL27 CCL28 CCR11 Agonists: CCL19 CCL21 CCL25 Ungrouped Antibodies: Bertilimumab (against CCL11) Carlumab (against CCL2)...
10 KB (962 words) - 22:42, 28 August 2024
Agonists: CCL25 CCR10 Agonists: CCL27 CCL28 CCR11 Agonists: CCL19 CCL21 CCL25 Ungrouped Antibodies: Bertilimumab (against CCL11) Carlumab (against CCL2)...
30 KB (2,931 words) - 10:43, 29 July 2024
Agonists: CCL25 CCR10 Agonists: CCL27 CCL28 CCR11 Agonists: CCL19 CCL21 CCL25 Ungrouped Antibodies: Bertilimumab (against CCL11) Carlumab (against CCL2)...
10 KB (1,231 words) - 22:00, 8 March 2024
Agonists: CCL25 CCR10 Agonists: CCL27 CCL28 CCR11 Agonists: CCL19 CCL21 CCL25 Ungrouped Antibodies: Bertilimumab (against CCL11) Carlumab (against CCL2)...
20 KB (2,419 words) - 23:03, 5 September 2024
Agonists: CCL25 CCR10 Agonists: CCL27 CCL28 CCR11 Agonists: CCL19 CCL21 CCL25 Ungrouped Antibodies: Bertilimumab (against CCL11) Carlumab (against CCL2)...
22 KB (2,786 words) - 02:02, 19 August 2024
Agonists: CCL25 CCR10 Agonists: CCL27 CCL28 CCR11 Agonists: CCL19 CCL21 CCL25 Ungrouped Antibodies: Bertilimumab (against CCL11) Carlumab (against CCL2)...
10 KB (930 words) - 21:55, 23 September 2024
Agonists: CCL25 CCR10 Agonists: CCL27 CCL28 CCR11 Agonists: CCL19 CCL21 CCL25 Ungrouped Antibodies: Bertilimumab (against CCL11) Carlumab (against CCL2)...
26 KB (2,934 words) - 23:08, 5 September 2024
Agonists: CCL25 CCR10 Agonists: CCL27 CCL28 CCR11 Agonists: CCL19 CCL21 CCL25 Ungrouped Antibodies: Bertilimumab (against CCL11) Carlumab (against CCL2)...
21 KB (2,612 words) - 11:46, 29 July 2024
Agonists: CCL25 CCR10 Agonists: CCL27 CCL28 CCR11 Agonists: CCL19 CCL21 CCL25 Ungrouped Antibodies: Bertilimumab (against CCL11) Carlumab (against CCL2)...
5 KB (642 words) - 21:49, 2 September 2023
Agonists: CCL25 CCR10 Agonists: CCL27 CCL28 CCR11 Agonists: CCL19 CCL21 CCL25 Ungrouped Antibodies: Bertilimumab (against CCL11) Carlumab (against CCL2)...
17 KB (1,685 words) - 07:47, 1 July 2024
(USAN) carisbamate (USAN) carisoprodol (INN) carlecortemcel-L (USAN) carlumab (USAN, INN) carmantadine (INN) carmegliptin (USAN, INN) carmellose (INN)...
16 KB (757 words) - 05:06, 19 June 2024
Agonists: CCL25 CCR10 Agonists: CCL27 CCL28 CCR11 Agonists: CCL19 CCL21 CCL25 Ungrouped Antibodies: Bertilimumab (against CCL11) Carlumab (against CCL2)...
14 KB (1,728 words) - 18:04, 16 April 2024
Agonists: CCL25 CCR10 Agonists: CCL27 CCL28 CCR11 Agonists: CCL19 CCL21 CCL25 Ungrouped Antibodies: Bertilimumab (against CCL11) Carlumab (against CCL2)...
14 KB (1,641 words) - 23:08, 5 September 2024
Agonists: CCL25 CCR10 Agonists: CCL27 CCL28 CCR11 Agonists: CCL19 CCL21 CCL25 Ungrouped Antibodies: Bertilimumab (against CCL11) Carlumab (against CCL2)...
9 KB (704 words) - 21:32, 3 September 2024
Agonists: CCL25 CCR10 Agonists: CCL27 CCL28 CCR11 Agonists: CCL19 CCL21 CCL25 Ungrouped Antibodies: Bertilimumab (against CCL11) Carlumab (against CCL2)...
12 KB (954 words) - 13:32, 23 April 2024
Agonists: CCL25 CCR10 Agonists: CCL27 CCL28 CCR11 Agonists: CCL19 CCL21 CCL25 Ungrouped Antibodies: Bertilimumab (against CCL11) Carlumab (against CCL2)...
20 KB (2,508 words) - 19:36, 5 September 2024
Agonists: CCL25 CCR10 Agonists: CCL27 CCL28 CCR11 Agonists: CCL19 CCL21 CCL25 Ungrouped Antibodies: Bertilimumab (against CCL11) Carlumab (against CCL2)...
22 KB (2,660 words) - 15:08, 13 July 2024
Agonists: CCL25 CCR10 Agonists: CCL27 CCL28 CCR11 Agonists: CCL19 CCL21 CCL25 Ungrouped Antibodies: Bertilimumab (against CCL11) Carlumab (against CCL2)...
22 KB (2,644 words) - 07:23, 4 September 2024
Agonists: CCL25 CCR10 Agonists: CCL27 CCL28 CCR11 Agonists: CCL19 CCL21 CCL25 Ungrouped Antibodies: Bertilimumab (against CCL11) Carlumab (against CCL2)...
9 KB (885 words) - 07:16, 30 April 2024
Agonists: CCL25 CCR10 Agonists: CCL27 CCL28 CCR11 Agonists: CCL19 CCL21 CCL25 Ungrouped Antibodies: Bertilimumab (against CCL11) Carlumab (against CCL2)...
19 KB (1,726 words) - 12:13, 3 December 2023
Agonists: CCL25 CCR10 Agonists: CCL27 CCL28 CCR11 Agonists: CCL19 CCL21 CCL25 Ungrouped Antibodies: Bertilimumab (against CCL11) Carlumab (against CCL2)...
33 KB (3,907 words) - 23:15, 21 September 2024
Agonists: CCL25 CCR10 Agonists: CCL27 CCL28 CCR11 Agonists: CCL19 CCL21 CCL25 Ungrouped Antibodies: Bertilimumab (against CCL11) Carlumab (against CCL2)...
4 KB (518 words) - 21:19, 21 November 2023
formula C6442H9966N1706O2018S40 (molar mass: 144.88 kg/mol) may refer to: Carlumab Crenezumab This set index page lists chemical structure articles associated...
319 bytes (50 words) - 20:05, 26 August 2022
Agonists: CCL25 CCR10 Agonists: CCL27 CCL28 CCR11 Agonists: CCL19 CCL21 CCL25 Ungrouped Antibodies: Bertilimumab (against CCL11) Carlumab (against CCL2)...
28 KB (3,148 words) - 11:43, 29 July 2024